Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank29
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.66
↓ 100% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
-2.33
Historical baseline
PeriodValueYoY Change
2024-4.66-26.4%
2023-3.69-48.1%
2022-2.49+72.6%
2021-9.08-1407.0%
2020-0.60+22.1%
2019-0.77-108.1%
2018-0.37+0.7%
2017-0.37+42.6%
2016-0.65-13.0%
2015-0.58-